Of note, subcutaneous and/or intravenous administration exhibits 100% bioavailability, with a half-life of 40 min. Potential routes of metabolism in humans include sulfation, N-demethylation, glucuronidation, and oxidation. [doi.org]

The species C. jejuni is the causative agent of about 90% of human campylobacteriosis cases worldwide and this disease may even end up in severe autoimmune sequelae as Guillain-Barré syndrome (GBS). [ncbi.nlm.nih.gov]

and the half-life is 8 to 9 h, with peak plasma levels within 6 h, but it may exhibit a wide range of side effects, such as acute dystonic reactions, pseudoparkinsonism, or akathisia. [doi.org]